You are here

Coronary Intervention & Surgery

 

An analysis of Medicare beneficiaries found that a transradial intervention during PCI was $916 cheaper and associated with less bleeding, fewer vascular complications and less transfusions than a transfemoral intervention.

A new study by researchers in London found more than 100 new gene regions associated with high blood pressure—a discovery that could help physicians identify at-risk patients and better target their treatments.

Tectonic shifts in healthcare delivery demand a broad collective skillset measured out among cardiologists, nurses, cardiology service line directors and practice administrators. Priorities need to focus on training and outreach from clinical, operational and financial perspectives as well as strengthening the heart team. Prairie Heart and Vascular Institute in Springfield, Ill., is part of one health system that is leading the way. Working from a mission and vision combining patient care with provider education—similar to the model in place at large academic medical centers—the practice is a judicious yet eager adopter of leading-edge technologies such as Abiomed’s Impella 2.5 heart pump, the smallest and least invasive percutaneous ventricular support blood pump. Care and caregiver collaboration is a constant. In short, Prairie daily demonstrates best practices that many other heart teams would do well to emulate.

A new cardiac imaging tool allows surgeons to repair serious residual holes in the heart that may occur when repairing a child’s heart defect.

In 2015, patients who underwent transcatheter aortic valve replacement (TAVR) had a decrease in in-hospital mortality and one-year mortality and an increase in 30-day post procedure pacemaker insertion, according to a registry analysis.

 

Recent Headlines

Transradial interventions, same-day discharges following PCIs save hospitals $300 million per year

An analysis of Medicare beneficiaries found that a transradial intervention during PCI was $916 cheaper and associated with less bleeding, fewer vascular complications and less transfusions than a transfemoral intervention.

Medinol hires Harvey Berger as executive chairman of its US operations

Medinol hired Harvey J. Berger, MD, as executive chairman of the company’s operations in the U.S.

FDA approves Biotronik’s cobalt chromium coronary stent system

The FDA approved the Pro-Kinetic energy cobalt chromium coronary stent system for patients with blockages in their coronary arteries.

Biosensors announces first patient has enrolled in polymer-free drug-coated stent trial

Biosensors International Group announced on Feb. 15 that the first patient had enrolled in a pivotal clinical trial evaluating the company’s BioFreedom polymer-free drug-coated stent.

Updated ACC registry data provides latest PCI trends

Recently, the ACC released updated data from CathPCI, which showed that more than 90 percent of PCI-capable hospitals in the U.S. used the registry. Of those sites, 70 percent submit data for all diagnostic catheterization and PCI procedures.

FDA clears Medtronic products for diagnostic cardiac catheterization procedures, PCIs

The FDA cleared Medtronic’s DxTerity diagnostic angiography catheter line and several of the company’s transradial-specific products, all of which are used in diagnostic cardiac catheterization procedures and PCIs.

HIV-infected patients may be more likely to have type 2 MIs

More than half of MIs among HIV-infected patients were classified as type 2 MIs that occurred in the setting of a mismatch between oxygen demand and supply, according to a longitudinal study.

Exela Pharma Sciences recalls ibuprofen lysine injection vials

Exela Pharma Sciences voluntarily recalled a lot of its ibuprofen lysine injection vials after discovering some of the vials contained particulate matter.

Tampa hospital performs 100th transcatheter pulmonary valve replacement

St. Joseph’s Children’s Hospital in Tampa, Florida, performed its 100th non-invasive heart surgery Feb. 6 in which it gave a patient a transcatheter pulmonary valve.

100 newly discovered blood pressure genes could help treat hypertension

A new study by researchers in London found more than 100 new gene regions associated with high blood pressure—a discovery that could help physicians identify at-risk patients and better target their treatments.

Pages